---
annotation-target: 1-s2.0-S022352342200513X-main.pdf
---


>%%
>```annotation-json
>{"created":"2022-09-07T09:05:49.513Z","updated":"2022-09-07T09:05:49.513Z","document":{"title":"Design, synthesis, and biological evaluation of pyrrolopyrimidine derivatives as novel Bruton's tyrosine kinase (BTK) inhibitors","link":[{"href":"urn:x-pdf:31e47b5694f44db7e5b08b4cf827108c"},{"href":"vault:/hematology-theroy/papers/hematology_deeplearning/1-s2.0-S022352342200513X-main.pdf"}],"documentFingerprint":"31e47b5694f44db7e5b08b4cf827108c"},"uri":"vault:/hematology-theroy/papers/hematology_deeplearning/1-s2.0-S022352342200513X-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/hematology_deeplearning/1-s2.0-S022352342200513X-main.pdf","selector":[{"type":"TextPositionSelector","start":2560,"end":2968},{"type":"TextQuoteSelector","exact":" BTK plays an essential role in B-cell receptor (BCR)-mediated activation and proliferation  by  regulating  the  factors  downstream  of  BCR,  such  as activation of the NF-κB and MAP kinase pathways [3]. Therefore, dys-regulation of BTK generally causes severe leukemias and B-cell-related lymphomas. In addition to its role in BCR signaling, BTK also plays a critical role in Fc receptor (FcR) signaling.","prefix":" plasma cells [1,2]. In B cells,","suffix":" Signaling  via  FcγR-associated"}]}]}
>```
>%%
>*%%PREFIX%%plasma cells [1,2]. In B cells,%%HIGHLIGHT%% ==BTK plays an essential role in B-cell receptor (BCR)-mediated activation and proliferation  by  regulating  the  factors  downstream  of  BCR,  such  as activation of the NF-κB and MAP kinase pathways [3]. Therefore, dys-regulation of BTK generally causes severe leukemias and B-cell-related lymphomas. In addition to its role in BCR signaling, BTK also plays a critical role in Fc receptor (FcR) signaling.== %%POSTFIX%%Signaling  via  FcγR-associated*
>%%LINK%%[[#^pg93i48dw|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^pg93i48dw
